Video

Q&A With Fulton Velez From Sunovion Pharmaceuticals: Using Health Economics And Outcomes Research In Epilepsy Treatment

Author(s):

There are many factors to consider when treating patients with epilepsy, from the number of medications they take to the impact of the condition on their daily lives. All these factors can help determine their overall quality of life.

There are many factors to consider when treating patients with epilepsy, from the number of medications they take to the impact of the condition on their daily lives. All these factors can help determine their overall quality of life.

Fulton Velez, MD, MS, MBA, who serves as Director of Health Economics And Outcomes Research at Sunovion Pharmaceuticals discussed research that was done in this area during the 69th Annual Meeting of the American Epilepsy Society in Philadelphia.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.